Catalyst Wire Dossier Catalyst Wire Dossier

LNK01001

· Lynk Pharmaceuticals Co., Ltd
Drug timelines are a Plus or Pro feature.

4 regulatory and trial events tracked for LNK01001, covering 2023-10-25 to 2025-11-20. Get the full timeline:

Most recent: Clinical Trial Update: A Study to Evaluate Efficacy and Safety of LNK01001 in Adults With Ankylosing Spondylitis [Phase 3]

See pricing